Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about 6 relevant journals, 436 Scientific conference proceedingsand 108 National symposiums are presently dedicated exclusively to Prostate disease and and about 157 Open Access Articles are being published on Prostate disease.
Approximately 3 million American men have some type of prostate disease. More than half of all men over the age of 65 develop BPH, and almost all men over 85 (about 90%) have it, making it one of the most common health problems for older men.Today, the interdisciplinary care of prostate cancer has become a reality, and urologists along with radiation, surgical, and medical oncologists are all involved in the management of these patients. In order to provide optimal care, it is essential that all members of the treatment team stay up-to-date on current trends and emerging data, not just in their own area, but also in the related specialties such as Prostate Cancer: What All Men Must Know, Prostate cancer: Current topics and future perspectives, Latest Research on Prostate Cancer, Treating Prostate Cancer and Prostate Cancer: Bone Metastases.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance
Prostate disease Conference provides the scope for opportunities to learn progressed by international scientists and academicians.Prostate disease or prostate cancer is a type of cancer which affects only men, where there is an abnormal or uncontrolled growth of prostate cells. Prostate is a part of male’s reproductive system; it is located in front of rectum and under the bladder. In some men prostate cancer can be slow growing and may live many years without ever having cancer detected. The risk factors of prostate cancer include Age, Genes, Race, Nationality, Diet, Obesity and Smoking and Workplace exposures. Symptoms include pain and difficulty passing urine, frequent need to pass urine and blood in urine or semen. If prostate cancer spreads to other parts of the body, symptoms like weight loss, pain in bones, back pain and loss of appetite are observed. Stages of prostate cancer include stage 1, stage 2, stage 3 and stage 4.Stage 1-cancer found in the prostate only. Stage 2-cancer which is more advanced than in stage 1, but it does not spread outside the prostate .Stage 3-cancer spreads outside the prostate and may spread to seminal vesicles. Stage 4-cancer spreads outside the prostate, to seminal vesicles and to nearby tissues or organs. Once prostate cancer has been diagnosed and staged, the person should discuss with his doctor to choose a treatment plan. The treatment options for men with prostate cancer may depend on the situation. The following are some of the treatment options: Expectant , Surgery , Radiation therapy , Cryosurgery (cryotherapy) , Hormone therapy , Chemotherapy , Vaccine treatment , Bone directed treatment.
Market Analysis
Global prostate cancer disease therapeutics market was valued at $2,713 million in 2010 and it is expected to reach $6,457 million, by 2020. It is estimated that the market will grow at a CAGR of 11.4% and 6.8% from 2010 to 2015 and 2015 to 2020 respectively.
International symposium and workshops
Prostate cancer world conference , August 18-21 -2015, Cairns, Queensland, Australia.
Global Congress on Prostate Cancer , February5-7,2015 -Rome, Italy.
Genitourinary Cancers Symposium, February 26-28, 2015, Orlando, Florida.
Advanced Prostate Cancer Consensus Conference, March 12-14, 2015, St Galen Switzerland.
List of Best International Conferences
Pancreatic and Colorectal Cancer Conference
March 29-30, 2016 Atlanta, USA.
4th Blood Malignancies Conference
April 18-20, 2016 Dubai, UAE.
Gynecologic Oncology Conference
May 19-21, 2016 San Antonio, USA.
2nd Antimicrobial Agents and Chemotherapy Conference
June 6-7, 2016 Dallas, USA.
Cancer Diagnostics Conference
June 13-15, 2016 Rome, Italy.
10 Global Oncologists Conference
July 11-13, 2016 Cologne, Germany.
11th Oncology and Oncologists Conference
July 11-13, 2016 Kuala Lumpur, Malaysia.
Melanoma and Carcinoma Conference
July 14-15, 2016 Brisbane, Australia.
Neuro Onclogy Conference
July 21-23, 2016 Brisbane, Australia.
Thyroid Cancer Conference
Aug 1-3, 2016 Toronto, Canada.
Oral, Mouth and Throat Cancer Conference
Aug 18-20, 2016 Portland, Oregon.
Molecular & Cancer Biomarkers Conference
Sept 15-17, 2016 Berlin, Germany.
Cervical Cancer Conference
Sept 22-23, 2016 Vienna, Austria.
Radiation Oncology Conference
Sep 26-28, 2016 Valencia, Spain.
12th Cancer Therapy Conference
Sept 26-28, 2016 London, UK.
13th Oncologists and Cancer Therapy Conference
Oct 17-19, 2016 Dubai, UAE.
Mesothelioma Conference
Nov 3-4, 2016 Valencia, Spain.
Leukemia and Bonemarrow Tranplantation Conference
Nov 10-12, 2016 Istanbul, Turkey.
14th Cancer Therapy Conference
Dec 8-10, 2016 Baltimore, USA.
Relevant Society and Associations
American Cancer Society.
Prostate Cancer Foundation.
Cancer Research UK.
British Association of Urological Surgeons (BAUS).
National Cancer Institute.
Prostate Cancer UK.
Prostate Cancer Canada.
Australian Prostate cancer Research Centre.
Prostate Cancer Foundation of Australia.
Urological Association of Asia and Iranian.
List of Companies
OncoGenex.
Prostate Cancer UK.
Dendreon.
Endo Pharmaceuticals.
Celgene.
deCODE genetics.
BTG.
Bavarian Nordic.
Exelixis.
Prostagene.
This page will be updated regularly.
This page was last updated on November 5, 2024
